MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

Search

ResMed Inc

Fechado

SetorSaúde

254.81 -1.44

Visão Geral

Variação de preço das ações

24h

Atual

Mín

254.29

Máximo

263.74

Indicadores-chave

By Trading Economics

Rendimento

-31M

349M

Vendas

-12M

1.3B

P/E

Médio do Setor

26.391

89.037

Rendimento de Dividendos

0.84

Margem de lucro

26.096

Funcionários

10,600

EBITDA

-29M

503M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+14.07% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.84%

2.18%

Próximos Ganhos

29 de jan. de 2026

Próxima data de dividendos

19 de mar. de 2026

Próxima data de ex-dividendo

12 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-231M

38B

Abertura anterior

256.25

Fecho anterior

254.81

Sentimento de Notícias

By Acuity

21%

79%

49 / 360 Ranking em Healthcare

ResMed Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

22 de jan. de 2026, 21:55 UTC

Ganhos

Capital One Financial Posts Higher 4Q Profit As Lending Increases

22 de jan. de 2026, 23:52 UTC

Ganhos

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- Update

22 de jan. de 2026, 23:48 UTC

Conversa de Mercado

Nikkei May Rise as Tensions Between U.S. and Europe Ease -- Market Talk

22 de jan. de 2026, 23:42 UTC

Conversa de Mercado

Gold Edges Lower on Possible Profit-Taking -- Market Talk

22 de jan. de 2026, 23:40 UTC

Conversa de Mercado

Spark NZ's Market Share Loss Concerns Bear -- Market Talk

22 de jan. de 2026, 23:30 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

22 de jan. de 2026, 23:30 UTC

Conversa de Mercado

Genesis Energy Can Beat Newly Upgraded Earnings Goal -- Market Talk

22 de jan. de 2026, 22:37 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Capital One CEO: Brex Buy Reflects Business Payments Focus -- Market Talk

22 de jan. de 2026, 21:59 UTC

Aquisições, Fusões, Aquisições de Empresas

Capital One Strikes $5.15 Billion Deal for Fintech Brex -- Update

22 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Tech, Media & Telecom Roundup: Market Talk

22 de jan. de 2026, 21:44 UTC

Ganhos

Self-Driving Stock Mobileye Plunged After Earnings. Here's Why. -- Barrons.com

22 de jan. de 2026, 21:32 UTC

Aquisições, Fusões, Aquisições de Empresas

Capital One: Brex Invented Integrated Combination of Corporate Credit Cards, Spend Management Software and Banking in Single Platform >COF

22 de jan. de 2026, 21:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Capital One: Brex Is a Modern, AI-native Software Platform Offering Intelligent Finance Solutions >COF

22 de jan. de 2026, 21:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Capital One: Franceschi Will Continue to Lead Brex as Part of Capital One >COF

22 de jan. de 2026, 21:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Capital One to Acquire Brex in Combination of Stk and Cash Transaction Valued at $5.15 B >COF

22 de jan. de 2026, 21:30 UTC

Ganhos

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results -- WSJ

22 de jan. de 2026, 21:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Capital One To Acquire Brex >COF

22 de jan. de 2026, 21:13 UTC

Ganhos

Intel Returns to Losses in Q4 as It Ramps Up Spending on Chip Production -- WSJ

22 de jan. de 2026, 21:11 UTC

Ganhos

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22 de jan. de 2026, 21:11 UTC

Ganhos

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22 de jan. de 2026, 21:10 UTC

Ganhos

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22 de jan. de 2026, 21:06 UTC

Ganhos

Capital One 4Q Total Non-Interest Expense Increased 13% to $9.3B >COF

22 de jan. de 2026, 21:05 UTC

Ganhos

Capital One 4Q Provision for Credit Losses Increased $4.1B >COF

22 de jan. de 2026, 21:05 UTC

Ganhos

Capital One 4Q Rev $15.58B >COF

22 de jan. de 2026, 21:05 UTC

Ganhos

Capital One 4Q EPS $3.26 >COF

22 de jan. de 2026, 21:05 UTC

Ganhos

Capital One 4Q Net Interest Margin 8.26% >COF

22 de jan. de 2026, 21:05 UTC

Ganhos

Capital One 4Q Net $2.13B >COF

22 de jan. de 2026, 21:05 UTC

Ganhos

Capital One 4Q Adj EPS $3.86 >COF

22 de jan. de 2026, 21:05 UTC

Ganhos

Capital One 4Q Net Charge-Offs $3.8B >COF

22 de jan. de 2026, 21:05 UTC

Ganhos

Intuitive Surgical 4Q EPS $2.21 >ISRG

Comparação entre Pares

Variação de preço

ResMed Inc Previsão

Preço-alvo

By TipRanks

14.07% parte superior

Previsão para 12 meses

Média 295.75 USD  14.07%

Máximo 345 USD

Mínimo 260 USD

Com base em 12 analistas de Wall Street que oferecem metas de preço de 12 meses para ResMed Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

12 ratings

7

Comprar

5

Manter

0

Vender

Sentimento

By Acuity

49 / 360 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat